The DBT-BIRAC Joint Call for Proposals on "Precision Biotherapeutics-Cell and Gene Therapy" aims to advance high-performance biomanufacturing in India, as outlined in the BioE3 Policy approved in August 2024. The initiative focuses on fostering innovation in Cell and Gene Therapy (CGT), a rapidly evolving field with transformative potential for treating complex diseases. Proposals are invited in two categories: (1) Discovery & Application-oriented Integrated Network Research (TRL: 3-5), which aims to advance gene delivery vectors, gene editing techniques, and cell-based therapies; and (2) Bridging the Gaps for Scale-up (TRL: 5-8), which targets clinical translation, scaling-up production, and clinical trials for CGTs. The call seeks proposals that foster collaboration between academia, industry, and clinical researchers, with a clear development plan, milestones, and risk management strategies. The funding will be available to both academic institutions and industry participants, with varying support based on project scope. The initiative aims to build indigenous capabilities, accelerate clinical advancements, and create affordable CGT candidates to contribute to India's bioeconomy and green growth.
Last date: Mar 15, 2025
